Log In
BCIQ
Print this Print this
 

METDoloron (NM0127)

  Manage Alerts
Collapse Summary General Information
Company Nanomerics Ltd.
DescriptionPain therapeutic based on a delta opioid receptor agonist
Molecular Target Opioid receptor delta 1 (OPRD1) (DOR)
Mechanism of ActionOpioid receptor agonist
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPhase I
Standard IndicationPain
Indication DetailsTreat moderate to severe pain
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today